BC DXH 609T analyzer cprr & reagents

Ended Awarded Last action

Contract number
N0025922F0166
Awardee
Awarding agency
Obligated
$150,375

Award facts

Contract value 98% obligated
$153,114.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Brea, CA 92822, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00012 $32,861
Supplemental Agreement for work within scope P00011 $0
Exercise an Option P00010 · Cost per test - hematology analyzer and reagents. $0
Supplemental Agreement for work within scope P00009 $18,919
Other Administrative Action P00008 · Laboratory analyzer, automated hematology with reagents, quality control materials, maintenance, and consumables $0
Funding Only Action P00007 · Hematology analyzer & reagents $32,865
Exercise an Option P00006 $0
Funding Only Action P00005 $32,865
Exercise an Option P00004 $0
Funding Only Action P00003 $32,865
Other Administrative Action P00002 $0
Exercise an Option P00001 · BC DXH 609T analyzer cprr & reagents option 1 $0
Original award DXH 609T analyzer cprr & reagents $2,739
Show all 13

About this award

Beckman Coulter, Inc., a subsidiary of Danaher Corporation, was awarded a delivery order valued at $153,114.12 by the Defense Health Agency on July 14, 2022, for the provision of a BC DXH 609T hematology analyzer and associated reagents on a cost-per-test basis. The contract is structured as a firm fixed-price delivery order under the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule and carries an ultimate completion date of September 30, 2026. The place of performance is located in Brea, California, where Beckman Coulter maintains its U.S. Customer Operations division. No set-aside designation was utilized in this competitive procurement.

This delivery order represents one component of Beckman Coulter's extensive federal healthcare contracting portfolio with the Defense Health Agency and Veterans Health Administration network. The company provides automated hematology diagnostic equipment and laboratory reagents essential to federal healthcare facility operations, with this specific order supporting the Defense Health Agency's core laboratory diagnostic capabilities. Beckman Coulter's established relationship with federal healthcare agencies is evidenced by multiple significant indefinite delivery contracts and blanket purchase agreements collectively valued in the tens of millions of dollars, positioning the company as a critical supplier of sophisticated medical diagnostic technologies across the federal healthcare system.

Quick answers

Who was awarded contract N0025922F0166?

N0025922F0166 was awarded to Beckman Coulter, Inc. by Defense Health Agency (Department of Defense) on July 14, 2022.

How much is contract N0025922F0166 worth?

The government has obligated $150,375 on N0025922F0166. Its current value, with exercised options, is $153,114.

Is contract N0025922F0166 an order under another contract?

Yes. N0025922F0166 is a delivery order under V797D70260, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract N0025922F0166 competed?

The extent of competition for N0025922F0166 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award